DOCT.L vs. XLVS.L
DOCT.L (L&G Healthcare Breakthrough UCITS ETF) and XLVS.L (Invesco Health Care S&P US Select Sector UCITS ETF Acc) are both Health & Biotech Equities funds - DOCT.L tracks the MSCI World/Health Care NR USD while XLVS.L tracks the S&P® Select Sector Capped 20% Health Care Index. Both are passively managed. Over the past 5 years, DOCT.L returned -3.81%/yr vs 5.76%/yr for XLVS.L. A 0.65 correlation means they provide meaningful diversification when combined. DOCT.L charges 0.49%/yr vs 0.14%/yr for XLVS.L.
Performance
DOCT.L vs. XLVS.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DOCT.L achieves a 0.41% return, which is significantly higher than XLVS.L's -2.10% return.
DOCT.L
- 1D
- 5.27%
- 1M
- 6.77%
- YTD
- 0.41%
- 6M
- 0.07%
- 1Y
- 31.20%
- 3Y*
- 7.08%
- 5Y*
- -3.81%
- 10Y*
- —
XLVS.L
- 1D
- 3.00%
- 1M
- 4.80%
- YTD
- -2.10%
- 6M
- -0.58%
- 1Y
- 15.13%
- 3Y*
- 6.54%
- 5Y*
- 5.76%
- 10Y*
- 9.17%
DOCT.L vs. XLVS.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
DOCT.L L&G Healthcare Breakthrough UCITS ETF | 0.41% | 24.88% | 1.98% | -1.20% | -33.86% | 0.19% | 66.94% | 5.40% |
XLVS.L Invesco Health Care S&P US Select Sector UCITS ETF Acc | -2.10% | 14.78% | 2.15% | 1.56% | -2.62% | 27.57% | 12.04% | 10.75% |
Correlation
The correlation between DOCT.L and XLVS.L is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.63 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Jul 3, 2019 | 0.65 |
The correlation between DOCT.L and XLVS.L has been stable across timeframes, ranging from 0.60 to 0.65 - a consistent structural relationship.
DOCT.L vs. XLVS.L - Sectors Allocation Comparison
Sectors
DOCT.L
XLVS.L
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
DOCT.L
XLVS.L
Technology
DOCT.L
XLVS.L
-
Basic Materials
DOCT.L
-
XLVS.L
-
Communication Services
DOCT.L
-
XLVS.L
-
Consumer Cyclical
DOCT.L
-
XLVS.L
-
Consumer Defensive
DOCT.L
-
XLVS.L
-
Energy
DOCT.L
-
XLVS.L
-
Financial Services
DOCT.L
-
XLVS.L
-
Industrials
DOCT.L
-
XLVS.L
-
Real Estate
DOCT.L
-
XLVS.L
-
Utilities
DOCT.L
-
XLVS.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DOCT.L vs. XLVS.L — Risk / Return Rank
DOCT.L
XLVS.L
DOCT.L vs. XLVS.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Breakthrough UCITS ETF (DOCT.L) and Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DOCT.L | XLVS.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.48 | ||
| Sortino ratioReturn per unit of downside risk | +0.64 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.18 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 1.82 | 1.44 | +0.38 |
| Martin ratioReturn relative to average drawdown | 4.42 | 3.56 | +0.86 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DOCT.L | XLVS.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.48 | 1.00 | +0.48 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | 0.39 | -0.55 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.59 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.64 | -0.40 |
Drawdowns
DOCT.L vs. XLVS.L - Drawdown Comparison
The maximum DOCT.L drawdown since its inception was -57.55%, which is greater than XLVS.L's maximum drawdown of -26.88%. Use the drawdown chart below to compare losses from any high point for DOCT.L and XLVS.L.
Loading charts...
Drawdown Indicators
| DOCT.L | XLVS.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.55% | -26.88% | -30.67% |
Max Drawdown (1Y)Largest decline over 1 year | -17.02% | -10.45% | -6.57% |
Max Drawdown (3Y)Largest decline over 3 years | -28.80% | -17.56% | -11.24% |
Max Drawdown (5Y)Largest decline over 5 years | -55.82% | -17.56% | -38.26% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.88% | — |
Current DrawdownCurrent decline from peak | -29.74% | -4.62% | -25.12% |
Average DrawdownAverage peak-to-trough decline | -29.05% | -4.88% | -24.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.04% | 4.24% | +2.80% |
Volatility
DOCT.L vs. XLVS.L - Volatility Comparison
L&G Healthcare Breakthrough UCITS ETF (DOCT.L) has a higher volatility of 6.75% compared to Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) at 4.89%. This indicates that DOCT.L's price experiences larger fluctuations and is considered to be riskier than XLVS.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DOCT.L | XLVS.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.75% | 4.89% | +1.86% |
Volatility (6M)Calculated over the trailing 6-month period | 15.76% | 10.78% | +4.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.03% | 15.07% | +5.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.01% | 14.74% | +9.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.76% | 15.53% | +9.23% |
DOCT.L vs. XLVS.L - Expense Ratio Comparison
DOCT.L has a 0.49% expense ratio, which is higher than XLVS.L's 0.14% expense ratio.
Dividends
DOCT.L vs. XLVS.L - Dividend Comparison
Neither DOCT.L nor XLVS.L has paid dividends to shareholders.
Frequently Asked Questions
DOCT.L and XLVS.L have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVS.L is cheaper at 0.14% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVS.L is cheaper with a 0.14% expense ratio, compared with 0.49% for DOCT.L.
DOCT.L tracks MSCI World/Health Care NR USD, while XLVS.L tracks S&P® Select Sector Capped 20% Health Care Index. They also come from different issuers: Legal & General and Invesco. Their fees differ too: 0.49% for DOCT.L and 0.14% for XLVS.L.
Find the right allocation for DOCT.L and XLVS.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer